The board of directors of Shenzhen Neptunus Interlong Bio-technique Company Limited to announce that Mr. Zhang Xiao Guang ("Mr. Zhang") has been appointed as an executive Director with effect from 25 June 2023. Mr. Zhang Xiao Guang, aged 57, graduated from China FAW Group Workers College, majoring in mechanical and electrical automation. Mr. Zhang has been working in the pharmaceutical industry for over 20 years and officially joined the Shenzhen Neptunus Group Company Limited in 2009. He has served as the sales manager, the provincial manager of Shanxi and Jilin provinces, the sales director of the north China region, and the deputy national sales supervisor and deputy national sales general manager of Shenzhen Neptunus Changjian Pharmaceutical Co. Ltd. ("Neptunus Changjian"). Mr. Zhang is currently the general manager of Neptunus Changjian. Mr. Zhang has extensive experience in sales management and has won multiple awards in the industry, including the Outstanding Management Team Award and Excellent Manager Award of the OTC Sales Department of Neptunus Changjian. A service agreement will be entered into between the Company and Mr. Zhang for a term of three years commencing from 25 June 2023 and ending on 24 June 2026. His appointment may be terminated by either party giving not less than three months' written notice to the other. He is entitled to receive a remuneration of RMB100,000 per annum (which is tax inclusive and to be paid on a monthly basis with the Company being responsible for withholding personal income tax). This remuneration has been
determined by the Board with reference to his duties, responsibilities and the performance and results of the Company, and shall be reviewed by the remuneration committee from time to time. Within the permitted scope regulated by relevant laws, regulations and policies of the PRC, any reasonable and necessary expenses (including but not limited to travel expenses) paid by Mr. Zhang for the provision of director's service to the Company or due to the execution of work relevant to matters for the Company's operation will be borne by the Company.
The Board announces that Mr. Shen Da Kai ("Mr. Shen") did not seek for re-election at the annual general meeting of the Company due to work arrangement. Therefore, the term of office of Mr. Shen will expire on 24 June 2023 and he will retire from his office as a non-executive Director. Mr. Shen has confirmed that he has no disagreement with the Board and the Company and there is no matter which needs to be brought to the attention of the shareholders of the Company in relation to his retirement.